Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, By Region, And Segment Forecasts, 2024

The global clinical nutrition for chronic kidney diseases market size is estimated to reach USD 2.37 billion by 2030, growing at a CAGR of 6.03% during the forecast period, according to a new report by Grand View Research, Inc. chronic kidney diseases (CKDs) present a substantial challenge, notably in low- and middle-income countries that lack adequate resources for effective management. Globally, CKD has emerged as a significant cause of death and is one of the rare non-communicable diseases experiencing an increase in mortality rates over the past two decades.

The rising global incidence of CKDs has led to the creation of a diverse array of nutritional supplements designed to address the specific dietary needs of CKD patients. This trend emphasizes the significance of continuous research and innovation in developing efficient and secure supplements that promote kidney health and overall well-being for individuals suffering from CKD.

The increasing awareness among the people and healthcare professionals to treat such deficiencies has resulted in the rising demand for oral clinical nutrition products. Research in natural compounds and nutraceuticals has expanded the scope for market growth. Some prominent examples include nutraceuticals comprising polyunsaturated fatty acids, phytosterols, and phenolic compounds. Moreover, plant-derived compounds such as resveratrol and curcumin have been proven effective in reducing oxidative stress, thus slowing CKD progression and the consequent cardiovascular threats.

Technological advancements in allied industries, such as enteral feeding devices, positively impact market growth. Key players are launching products that can be administered through the enteral route, propelling the market growth. Furthermore, government support in the form of approvals is anticipated to fuel the market growth over the forecast period.

Clinical Nutrition For Chronic Kidney Diseases Market Report Highlights:

Unhealthy lifestyles have led to the increasing burden of health issues such as lack of nutrition, obesity, poor immunity leading to the rise of chronic, neurological and autoimmune diseases.
Mergers, collaborations, partnerships, and product expansions characterize the market and propel market growth.
Oral nutrition dominated the product segment with a share of over 50% in 2023; however, parenteral formulas are anticipated to register lucrative growth in the future.
Adults led the stage segment with a revenue share of 85%. Individuals in the adult age group are increasingly experiencing decreased muscle strength, vitamin and calcium deficiencies, particularly among women over 30 years old, which has led to the segment growth.
Advancements in telemedicine have enabled the global distribution of clinical nutrition products, allowing manufacturers to broaden their market reach and cater to underserved communities. Thus, online sales are expected to aid market growth greatly over the forecast period.
Asia Pacific is anticipated to register the fastest CAGR of nearly 7% over the forecast period, owing to the increasing manufacturing facilities in the region and increased per capita healthcare expenditure.

Product Code: GVR-4-68040-281-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Stage
- 1.2.3. Sales Channel
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Stage Outlook
- 2.2.3. Sales Channels Outlook
- 2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Global Clinical Nutrition for Chronic Kidney Diseases Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Market opportunity analysis
3.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Estimates & Trend Analysis

4.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Dashboard
4.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Movement Analysis
4.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Oral Nutrition
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Parenteral Nutrition
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Enteral Feeding Formulas
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Estimates & Trend Analysis

5.1. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Dashboard
5.2. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Movement Analysis
5.3. Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. Adult
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Pediatric
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Estimates & Trend Analysis

6.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Dashboard
6.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Movement Analysis
6.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Online
- 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Retail
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Institutional Sales
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Clinical Nutrition for Chronic Kidney Diseases Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. U.S.
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
- 7.6.1. UK
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/ reimbursement structure
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/ reimbursement structure
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Denmark
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/ reimbursement structure
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework/ reimbursement structure
  - 7.6.7.3. Competitive scenario
  - 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Norway
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Regulatory framework/ reimbursement structure
  - 7.6.8.3. Competitive scenario
  - 7.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
- 7.7.1. China
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Japan
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. Thailand
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/ reimbursement structure
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. South Korea
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Regulatory framework/ reimbursement structure
  - 7.7.6.3. Competitive scenario
  - 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Regulatory framework/ reimbursement structure
  - 7.8.1.3. Competitive scenario
  - 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Mexico
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/ reimbursement structure
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Argentina
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework/ reimbursement structure
  - 7.8.3.3. Competitive scenario
  - 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
- 7.9.1. South Africa
  - 7.9.1.1. Key country dynamics
  - 7.9.1.2. Regulatory framework/ reimbursement structure
  - 7.9.1.3. Competitive scenario
  - 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Regulatory framework/ reimbursement structure
  - 7.9.2.3. Competitive scenario
  - 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Regulatory framework/ reimbursement structure
  - 7.9.3.3. Competitive scenario
  - 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Regulatory framework/ reimbursement structure
  - 7.9.4.3. Competitive scenario
  - 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Abbott Nutrition
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Product benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Pfizer Inc.
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Product benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. Bayer AG
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Product benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Nestle Health Science S.A.
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Product benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. GlaxoSmithKline plc
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Product benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Baxter International Inc.
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Product benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Otsuka Holdings Co., Ltd.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Product benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. Mead Johnson & Company, LLC
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Product benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Danone Nutricia
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Product benchmarking
  - 8.3.12.4. Strategic initiatives
- 8.3.13. Victus, Inc.
  - 8.3.13.1. Company overview
  - 8.3.13.2. Financial performance
  - 8.3.13.3. Product benchmarking
  - 8.3.13.4. Strategic initiatives

Product Code: GVR-4-68040-281-1

List of Tables

Table 1 List of abbreviation
Table 2 Global clinical nutrition for chronic kidney diseases market, 2018 - 2030 (USD Million)
Table 3 Global clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 4 Global clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 5 Global clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 6 North America clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
Table 7 North America clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 8 North America clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 9 North America clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 10 U.S. clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 12 U.S. clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 13 Canada clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 14 Canada clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 15 Canada clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 16 Europe clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
Table 17 Europe clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 18 Europe clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 19 Europe clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 20 UK clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 21 UK clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 22 UK clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 23 Germany clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 24 Germany clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 25 Germany clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 26 France clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 27 France clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 28 France clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 29 Italy clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 30 Italy clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 31 Italy clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 32 Spain clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 33 Spain clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 34 Spain clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 35 Denmark clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 37 Denmark clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 38 Sweden clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 40 Sweden clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 41 Norway clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 42 Norway clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 43 Norway clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 47 Asia Pacific clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 48 China clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 49 China clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 50 China clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 51 Japan clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 52 Japan clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 53 Japan clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 54 India clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 55 India clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 56 India clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 57 Australia clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 58 Australia clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 59 Australia clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 60 Thailand clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 62 Thailand clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 63 South Korea clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 65 South Korea clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 66 Latin America clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 69 Latin America clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 70 Brazil clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 72 Brazil clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 73 Mexico clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 75 Mexico clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 76 Argentina clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 78 Argentina clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 79 MEA clinical nutrition for chronic kidney diseases market, by country, 2018 - 2030 (USD Million)
Table 80 MEA clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 81 MEA clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 82 MEA clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 83 South Africa clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 85 South Africa clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 89 UAE clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 90 UAE clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 91 UAE clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)
Table 92 Kuwait clinical nutrition for chronic kidney diseases market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait clinical nutrition for chronic kidney diseases market, by stage, 2018 - 2030 (USD Million)
Table 94 Kuwait clinical nutrition for chronic kidney diseases market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Clinical nutrition for chronic kidney diseases market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter's five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Clinical nutrition for chronic kidney diseases market: Product outlook and key takeaways
Fig. 16 Clinical nutrition for chronic kidney diseases market: Product movement analysis
Fig. 17 Oral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Parenteral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Enteral feeding formulas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Clinical nutrition for chronic kidney diseases market: Stage outlook and key takeaways
Fig. 21 Clinical nutrition for chronic kidney diseases market: Stage movement analysis
Fig. 22 Adult market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Clinical nutrition for chronic kidney diseases market: Sales channel outlook and key takeaways
Fig. 25 Clinical nutrition for chronic kidney diseases market: Sales channel movement analysis
Fig. 26 Online market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Retail market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Clinical nutrition for chronic kidney diseases market revenue, by region, 2023 & 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways (1/2)
Fig. 31 Regional marketplace: Key takeaways (2/2)
Fig. 32 North America clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 U.S. clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Canada clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Europe clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 UK clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 Germany clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 France clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Italy clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Spain clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Denmark clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Sweden clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Norway clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Asia Pacific clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 China clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Japan clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 India clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Australia clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Thailand clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 South Korea clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Latin America clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Brazil clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Mexico clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Argentina clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 MEA clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Africa clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Saudi Arabia clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 UAE clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Kuwait clinical nutrition for chronic kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Company market share analysis, 2023
Fig. 89 Strategic framework

Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

Clinical Nutrition For Chronic Kidney Diseases Market Growth & Trends:

Clinical Nutrition For Chronic Kidney Diseases Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Clinical Nutrition for Chronic Kidney Diseases Market Variables, Trends & Scope

Chapter 4. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Estimates & Trend Analysis

Chapter 5. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Estimates & Trend Analysis

Chapter 6. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Estimates & Trend Analysis

Chapter 7. Global Clinical Nutrition for Chronic Kidney Diseases Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures